A group from China Medical University revealed that MEG3 may be a potential biomarker for epithelial ovarian cancer (EOC) and acts as a tumor suppressor in EOC by modulating autophagy-related 3 (ATG3) activity and triggering autophagy (Xiu et al., 2017). Here, ATG3 is linked to neoplasm.